White James G, Ahlstrand Gilbert G
Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis, Minnesota 55455, USA.
Platelets. 2003 Aug;14(5):313-24. doi: 10.1080/09537100310001594534.
Platelets from a mother and son with prolonged thrombocytopenia were shown in previous studies to contain giant organelles that developed in megakaryocytes and continued to evolve in circulating cells. Whole mount platelet preparations revealed that the large organelles were electron opaque like the serotonin-rich dense bodies in normal and patient platelets, and analytical electron microscopy revealed they contained large amounts of calcium and phosphorous in a ratio close to that found in normal platelet dense bodies. However, differences in physiology, biochemistry and morphology indicated the large opaque bodies and target-organelles in patient platelets were not aberrant dense bodies. The present study has shown that the giant organelles contain peroxidase activity like primary lysosomes in polymorphonuclear (PMN) leukocytes. Further, the giant organelles in patient platelets contain acid phosphatase activity. Analytical electron microscopy demonstrated that cerium, the capture ion for the acid phosphatase reaction product, was present in the opaque organelles with calcium and phosphorous, but not present in their normal dense bodies. Since normal sized lysosomes appeared to be reduced in patient platelets, it was concluded that the large structures were abnormal lysosomes, or fused with normal platelet lysosomes during their development. Similar giant lysosomes were not present in other patient blood cells. As a result the disorder can be considered a unique lysosomal disease of platelets.
先前的研究表明,患有血小板减少症的一对母子的血小板含有在巨核细胞中形成并在循环细胞中持续演变的巨大细胞器。整装血小板制剂显示,这些大细胞器像正常和患者血小板中富含5-羟色胺的致密小体一样呈电子不透明,分析电子显微镜显示它们含有大量钙和磷,其比例与正常血小板致密小体中的比例相近。然而,生理学、生物化学和形态学上的差异表明患者血小板中的大不透明体和靶细胞器并非异常致密小体。本研究表明,这些巨大细胞器具有与多形核(PMN)白细胞中的初级溶酶体相似的过氧化物酶活性。此外,患者血小板中的巨大细胞器含有酸性磷酸酶活性。分析电子显微镜表明,作为酸性磷酸酶反应产物捕获离子的铈存在于含有钙和磷的不透明细胞器中,但不存在于其正常致密小体中。由于患者血小板中正常大小的溶酶体似乎减少,因此得出结论,这些大结构是异常溶酶体,或者在其发育过程中与正常血小板溶酶体融合。其他患者血细胞中不存在类似的巨大溶酶体。因此,这种疾病可被视为一种独特的血小板溶酶体疾病。